Objective: To evaluate common clinical presentation, complications and poor prognostic outcomes in children with acute myocarditis.
Study Design: Prospective longitudinal study.
Place and Duration of Study: Pediatric Cardiology Department, National Institute of Cardiovascular Disease Karachi Pakistan, from Feb to Aug 2020.
Methodology: The children aged one month to 16 years were included in the study. Clinical, demographic features, Electrocardiogram, Echocardiography, management, complications, and immediate outcomes were recorded.
Results: The total number of patients enrolled was 161. The median age was 5.01 ± 3.38 years for 66.4% of males and 33.5% females, mean Duration of symptoms was 8.35 ± 3.49 days. Upper respiratory tract infection was present in 84 (52.2%) and diarrhea in 8 (5%) in the preceding illness. Symptoms and signs include loss of appetite in 153 (96.27%), irritability in 148 (91.9%), vomiting in 132 (82%) and abdominal pain in 112 (69.6%), tachycardia in 148 (91.9%) and pallor in 143 (88.8%). Low voltage ECG was present in 125 (77.6%), arrhythmias in 12 (7.45%) and heart block in 6 (3.7%). Left ventricle end-diastolic dimensions (LVIDD)>4SD were present in 30.2% and LV end-systolic dimensions (LVIDS)>4SD in 19.5%, Left ventricular ejection fraction (LVEF)mean was 21.13 ± 5.07 vs 23.45 ± 3.31 at discharge. 9.21% of patients expired, out of which 78.5% had Left bundle branch block (LBBB), mean LVEF was 16.24 ± 3.16, LVID d>4SD in 78%, and LVIDs>4SD in 30%.
Conclusion: The most frequent presentations were loss of appetite, difficulty breathing, irritability and abdominal pain. Tachycardia and pallor were......
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.